VWR International LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:VWR International LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12389
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshener dispensers, air regulation valves, aluminum foil, analog block heaters, analog hygrometers, analog multimeters, analog stopwatches, analytical balances, analytical funnels, animal feeding needles, animal implant needles, antibodies, antibody purification buffers, anti-fatigue floor mats, anti-slip tapes and antistatic brushes, among others. It also provides catalyst, custom manufacturing, e-commerce and VWR mobile technology services. The company caters to pharmaceutical, biotechnology, industrial, education, government and healthcare industries. The company markets its products in the US and abroad. VWR is headquartered in Radnor, Pennsylvania, the US.

VWR International LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VWR International LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
VWR International LLC, Medical Devices Deals, 2012 to YTD 2018 9
VWR International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
VWR International LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 11
Debt Offering 12
VWR Completes Private Placement Of Notes Due 2017 For US$750 Million 12
Acquisition 13
VWR International Acquires Reliable Biopharma and BioArra 13
VWR International Acquires Therapak, and Therapak Pharma Services 14
VWR International Acquires National Biochemicals 15
VWR International Acquires LABRepCo 16
VWR International To Acquire Peqlab Biotech 17
VWR International Acquires United Biochemicals 18
VWR International Acquires Prolab Laboratuar Teknolojileri, Scientific Lab Supplies Distributor 19
VWR International Acquires Lab3, Scientific Laboratory Products Distributor 20
VWR International Acquires Sovereign, Laboratory Products Distributor 21
VWR International LLC – Key Competitors 22
VWR International LLC – Key Employees 23
VWR International LLC – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Strategy And Business Planning 26
Feb 08, 2018: VWR and EPL open new GxP archive & biorepository facility 26
Aug 22, 2017: VWR Showcases New 125,000 Square Foot Regional Distribution Center 27
Government and Public Interest 28
Mar 13, 2017: The VWR Foundation Advances Science with Over $129,000 in First Quarter Grants 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
VWR International LLC, Pharmaceuticals & Healthcare, Key Facts 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VWR International LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VWR International LLC, Deals By Therapy Area, 2012 to YTD 2018 8
VWR International LLC, Medical Devices Deals, 2012 to YTD 2018 9
VWR International LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
VWR International Enters Into Distribution Agreement With Thermo Fisher Scientific 11
VWR Completes Private Placement Of Notes Due 2017 For US$750 Million 12
VWR International Acquires Reliable Biopharma and BioArra 13
VWR International Acquires Therapak, and Therapak Pharma Services 14
VWR International Acquires National Biochemicals 15
VWR International Acquires LABRepCo 16
VWR International To Acquire Peqlab Biotech 17
VWR International Acquires United Biochemicals 18
VWR International Acquires Prolab Laboratuar Teknolojileri, Scientific Lab Supplies Distributor 19
VWR International Acquires Lab3, Scientific Laboratory Products Distributor 20
VWR International Acquires Sovereign, Laboratory Products Distributor 21
VWR International LLC, Key Competitors 22
VWR International LLC, Key Employees 23
VWR International LLC, Subsidiaries 24

List of Figures
VWR International LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VWR International LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VWR International LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
VWR International LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[VWR International LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HiQ International AB (HIQ):企業の財務・戦略的SWOT分析
    Summary HiQ International AB (HiQ International) is a technology and communication company that offers management consultancy services. The company offers communication solutions, development of software, and business-critical IT systems. It provides services in the areas of telecom media, gaming an …
  • Sing Investments & Finance Ltd (S35):企業の財務・戦略的SWOT分析
    Sing Investments & Finance Ltd (S35) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Exillon Energy Plc (EXI):石油・ガス:M&Aディール及び事業提携情報
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Maxim Integrated Products, Inc.:企業の戦略・SWOT・財務分析
    Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Toro Energy Limited (TOE):企業の戦略的SWOT分析
    Toro Energy Limited (TOE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ana Holdings Inc
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Delfi Limited:企業の戦略・SWOT・財務情報
    Delfi Limited - Strategy, SWOT and Corporate Finance Report Summary Delfi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hinduja Global Solutions Ltd (HGS):企業の財務・戦略的SWOT分析
    Hinduja Global Solutions Ltd (HGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mobidiag Ltd:企業の製品パイプライン分析2018
    Summary Mobidiag Ltd (Mobidiag) is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestin …
  • Applied Industrial Technologies Inc (AIT):石油・ガス:M&Aディール及び事業提携情報
    Summary Applied Industrial Technologies Inc. (Applied Industrial) is a distributor of industrial products and services to MRO and OEM customers. The company also provides engineering, design and systems integration services for industrial and fluid power applications, besides tailored mechanical, fa …
  • Rezolute Inc (RZLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Rezolute Inc (Rezolute) formerly known as AntriaBio Inc, is a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for the treatment of metabolic and orphan diseases. Its pipeline product portfolio includes AB101, a microsphere formulation of …
  • Baxter International Inc (BAX)-製薬・医療分野:企業M&A・提携分析
    Summary Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products for the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-cent …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • The Magstim Co Ltd:企業の戦略的SWOT分析
    The Magstim Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Intercede Group plc (IGP):企業の財務・戦略的SWOT分析
    Intercede Group plc (IGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Zafgen Inc (ZFGN):企業の財務・戦略的SWOT分析
    Summary Zafgen Inc (Zafgen) is a clinical-stage biopharmaceutical company that develops transformative therapies for patients affected by a range of metabolic diseases. Its pipeline product portfolio includes ZGN-1061, a small molecule MetAP2 inhibitor being developed for patients with type 2 diabet …
  • Quilvest Wealth Management:企業の戦略・SWOT・財務情報
    Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Quilvest Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆